June 19th 2024
A survey of health system specialty pharmacy employees found that hybrid work significantly improved quality of life and workplace productivity.
Wolters Kluwer releases Trissel's IV-check APIv3.1
May 28th 2007Wolters Kluwer Health announced the introduction of Trissel's IV-CHEK API v3.1 (Trissel's IV-CHECK), which combines data from Trissel's 2, with Medi-Span integrated software. The combination will enable clinicians to access parenteral drug compatibility information from within their professional work flow computer systems.
New protocol for handling EGFR inhibitor skin reactions
May 28th 2007An article in the May 2007 issue of The Oncologist proposes a new system for handling skin toxicities associated with epidermal growth factor receptor (EGFR) inhibitors, an adverse reaction that ranges in type and severity and occurs in more than half of treated patients.
Should feds limit coverage of antianemia agents?
May 21st 2007CMS proposes paying for darbepoetin (Aranesp, Amgen) and epoetin alfa (Epogen, Amgen; Procrit, Ortho Biotech) only to treat anemia in certain cancer patients. Still to be considered is the use of the antianemia drugs among patients with kidney failure.
Bar-coding/e-MARs offer comfort of a safety net
May 21st 2007The ability of bedside bar-code administration and electronic MARs to catch adverse events and medication errors before they reach patients and then to generate reports and track emerging trends is revolutionizing the way that pharmacists, nurses, and physicians are managing patient safety concerns
Michigan ranks among top states in teen abuse of Rx drugs
May 7th 2007Michigan ranks among top states in teen abuse of Rx drugs The White House Office of National Drug Control Policy (ONDCP) and local Detroit experts urged parents to take action against the alarmingly high rate of teen prescription drug abuse in Michigan.
Premier introduces tools to manage pharmacy performance
May 7th 2007Beginning on April 30, participating members have been able to more effectively manage the performance programs from seven more drug- companies, including ReoPro (abciximab) from Eli Lilly and Integrilin (eptifibatide) from Schering.
WHO unveils nine patient safety solutions
May 7th 2007The Patient Safety Solutions address the issues of: look-alike, sound-alike medication names; correct patient identification; handover communications; correct procedure at the correct body site; control of concentrated electrolyte solutions; medication accuracy; catheter and tubing misconnections; needle reuse and injection device safety; and hand hygiene.